SAB Biotherapeutics Inc (SABS) — Cash Flow Reinvestment Rate
SAB Biotherapeutics Inc (SABS) has a Cash Flow Reinvestment Rate of 41.94x as of December 2022, reinvesting $9.09 Million (capex $117.75K plus investments $-8.97 Million) from operating cash flow of $216.72K. Explore SAB Biotherapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SAB Biotherapeutics Inc Cash Flow Reinvestment Rate (2020–2021)
Historical reinvestment intensity for SAB Biotherapeutics Inc across 2 annual periods. Also explore SAB Biotherapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for SAB Biotherapeutics Inc (2020–2021)
Year-by-year capital reinvestment analysis for SAB Biotherapeutics Inc. For live market cap and broader valuation context, see SABS company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 11.02x | $21.89 Million | $1.99 Million | $10.94 Million | ▲ +333.0% |
| 2020 | 2.54x | $25.45 Million | $10.00 Million | $12.73 Million | — |